Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study.
Vivienne KahlmannMontse Janssen BonásCatharina C MoorColine H M van MoorselMirjam KoolRaisa KraaijvangerJan C GruttersMayka OvergaauwMarcel VeltkampMarlies S Wijsenbeeknull nullPublished in: BMC pulmonary medicine (2020)
The study was registered on the 19th of March 2020 in the International Clinical Trial Registry, www.clinicaltrials.gov; ID NCT04314193 .